The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Agreed.The due diligence should be straightforward enough as we are not selling a company with all the possible skeletons to check out .
Having announced they are seeking a buyer or partner for StoneChecker on the 18th December I would suggest that the Company will be obligated to update the market well before the summer. My guess is that an update would be due at 3 months which would be by mid March. Let’s see...
The idea of a news release for the sale of stonechecker will start to lose momentum especially when we get into the summer months and still havnt heard anything.
#bekind
Completely wrong and disillusional. I really hope iqai hasn’t driven you mad with dreams of stonechecker being sold for millions of dollars and I hope you haven’t bet the house either.
Any information that is not yet in the public domain, which could be considered price-sensitive and may have an impact on the share price, will prevent directors from trading shares in the business. The legalities around this are very strict and the trading window for directors is often fraught with difficulty.
Any discussion with a third party about the potential sale of part of a business (in this case StoneChecker) will create a closed period for Directors of the business. This is particularly true because the Company have previously announced their intention to approach Companies and Directors will now have a good idea of that the interest is and the type of transactions are possible, or equally not possible. Both are price sensitive. A deal does not have to be agreed to create a closed period. This is to prevent Directors benefiting from their insider information.
unless an individual and/or a company have made an offer for stonechecker and iqai have accepted the offer but have not made that news public yet then yes iqai would be in blackout but if there just trying to flog a product but have accepted no offers then the company would certainly not be in blackout mode. We have no evidence of what’s going on so it’s all speculation until an rns is released. I for one would be very concerned that DS is no longer at the helm that just reeks trouble at the top. Next they will be saying they are re-evaluating there corporate strategy because as it stands iqai are sending out some real mixed messages.
Hi Geeforce, I agree, they are in a closed period until they formally withdraw their stated intention since information either way is material.
Tech, IQAI publicly have put a FDA approved product up for sale with a firm of bankers, potential value of sale in the millions possibly and will have a material impact on share price so you are correct, company in a close period, directors cannot not buy shares, TB is up to his neck in shares and the Schimindas (spelling) are to.
If the directors are talking to perspective companies, which they are because they have publicly stated they are, then they are not allowed to buy or sell shares during the discussion period, it would be a closed period until they sate they are no longer looking to sell the product to a third party. Any discussion is material wither it is at an early or late stage.
Come on guys, they've announced they are looking for a buyer for the product so it's not speculation it's a consequence of the previous announcement if they have managed to move forward with their stated intent.
That’s speculation that there is actually a deal on the table we have no evidence of such news so you shouldn’t state that directors are unable to purchase shares for this reason. Only time directors are restricted from purchasing shares is if the company is in blackout mode.
Directors would not be able to buy during ongoing negotiations as it would be considered price sensitive I think?
Arent the directors other than TB buying?
They arent closed as such